Pyridine → N-(2-(piperidin-1-yl)phenyl)isoxazole-5-carboxamide

HRID 33464

반응식

HRID 33464 반응식
C1C=CC(CNS(C2C=CC3N=NN(O)C=3C=2)(=O)=O)=CC=1.Cl.N1C=CC=CC=1.[O:29]1[C:33]([C:34](Cl)=[O:35])=[CH:32][CH:31]=[N:30]1.[N:37]1([C:43]2[CH:49]=[CH:48][CH:47]=[CH:46][C:44]=2[NH2:45])[CH2:42][CH2:41][CH2:40][CH2:39][CH2:38]1>O1CCCC1.ClCCl>[N:37]1([C:43]2[CH:49]=[CH:48][CH:47]=[CH:46][C:44]=2[NH:45][C:34]([C:33]2[O:29][N:30]=[CH:31][CH:32]=2)=[O:35])[CH2:42][CH2:41][CH2:40][CH2:39][CH2:38]1

참가 물질

7

실험 절차

To PS-HOBt resin (0.1 mmol) was added anhydrous dichloromethane (“DCM”) (1 mL) followed by pyridine (0.5 mmol) and isoxazole-5-carbonyl chloride (Lancaster) (0.3 mmol). The mixture was shaken at room temperature for 3 h and was then filtered. The resin was washed successively with tetrahydrofuran (“THF”) (3×) and DCM (3×) and dried in vacuo. To this acylated resin was added a solution of 2-piperidinoaniline (Lancaster) (0.05 mmol, 0.5 eq) in anhydrous THF (1 mL) and the mixture was shaken at room temperature for 16 h. The mixtue was then filtered and the resin washed with THF and DCM as described above. The combined filtrate and washings were concentrated under reduced pressure to yield the product. Yield: 100%. MS: 272 (M+1). LC/MS purity: 100%. 1HNMR (CDCl3, 300 MHz): δ 8.2 (d, 1H), 7.85 (t, 2H), 7.55 (m, 1H), 7.4 (m, 2H), 3.8-3.2 (bm, 4H), 2.7-1.9 (bm, 4H).

후처리

  1. filtrationwas then filtered
  2. washThe resin was washed successively with tetrahydrofuran (“THF”) (3×) and DCM (3×)
  3. customdried in vacuo
  4. stirringthe mixture was shaken at room temperature for 16 h
  5. filtrationThe mixtue was then filtered
  6. washthe resin washed with THF and DCM
  7. concentrationThe combined filtrate and washings were concentrated under reduced pressure
  8. customto yield the product

출처 및 근거

ORD 기록
ord-cc1fc177866d45a0b0846b9269bdeffc
출처 데이터셋
uspto-grants-2008_09
특허 번호
US07429603B2

연결된 노트

불러오는 중…